Lyuben Tsvetkov

2.5k total citations · 1 hit paper
19 papers, 1.8k citations indexed

About

Lyuben Tsvetkov is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Lyuben Tsvetkov has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Cell Biology. Recurrent topics in Lyuben Tsvetkov's work include DNA Repair Mechanisms (10 papers), Cancer-related Molecular Pathways (10 papers) and Ubiquitin and proteasome pathways (7 papers). Lyuben Tsvetkov is often cited by papers focused on DNA Repair Mechanisms (10 papers), Cancer-related Molecular Pathways (10 papers) and Ubiquitin and proteasome pathways (7 papers). Lyuben Tsvetkov collaborates with scholars based in United States, Bulgaria and France. Lyuben Tsvetkov's co-authors include Hui Zhang, Hong Sun, Kun‐Huei Yeh, David F. Stern, Xingzhi Xu, Jia Li, Ramanaiah Mamillapalli, Nadia J. Gavrilova, Valia T. Mihaylova and Hong Wu and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Current Biology.

In The Last Decade

Lyuben Tsvetkov

19 papers receiving 1.8k citations

Hit Papers

p27Kip1 ubiquitination and degradation is regulated by th... 1999 2026 2008 2017 1999 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyuben Tsvetkov United States 14 1.4k 1.1k 426 194 180 19 1.8k
David H. Randle United States 7 1.5k 1.1× 1.3k 1.1× 208 0.5× 144 0.7× 268 1.5× 9 1.9k
Amina F.A.S. Teunisse Netherlands 21 1.3k 0.9× 1.2k 1.0× 220 0.5× 135 0.7× 284 1.6× 37 1.7k
Virginia Amador Spain 18 1.5k 1.0× 900 0.8× 366 0.9× 125 0.6× 189 1.1× 28 2.0k
Frank Eckerdt United States 23 1.2k 0.8× 602 0.5× 568 1.3× 118 0.6× 196 1.1× 43 1.6k
Micaela Quarto Italy 16 1.5k 1.1× 773 0.7× 159 0.4× 204 1.1× 318 1.8× 18 1.9k
Andrea Cocito Italy 9 2.0k 1.4× 683 0.6× 274 0.6× 130 0.7× 332 1.8× 11 2.3k
Leandros-Vassilios Vassiliou United Kingdom 3 1.4k 1.0× 734 0.7× 241 0.6× 98 0.5× 297 1.6× 4 1.6k
Ellen Freed United States 12 1.5k 1.0× 659 0.6× 543 1.3× 131 0.7× 169 0.9× 14 2.1k
Lili Yamasaki United States 19 1.8k 1.3× 1.3k 1.2× 380 0.9× 104 0.5× 254 1.4× 23 2.3k

Countries citing papers authored by Lyuben Tsvetkov

Since Specialization
Citations

This map shows the geographic impact of Lyuben Tsvetkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyuben Tsvetkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyuben Tsvetkov more than expected).

Fields of papers citing papers by Lyuben Tsvetkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyuben Tsvetkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyuben Tsvetkov. The network helps show where Lyuben Tsvetkov may publish in the future.

Co-authorship network of co-authors of Lyuben Tsvetkov

This figure shows the co-authorship network connecting the top 25 collaborators of Lyuben Tsvetkov. A scholar is included among the top collaborators of Lyuben Tsvetkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyuben Tsvetkov. Lyuben Tsvetkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
de, Rocío Montes, Sabyasachi Bhattacharya, Laura Seestaller‐Wehr, et al.. (2019). PF558 THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE-MEDIATED ANTI-TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY. HemaSphere. 3(S1). 231–231. 14 indexed citations
2.
Liu, Li, Patrick A. Mayes, Stephen D. Eastman, et al.. (2015). The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. Clinical Cancer Research. 21(7). 1639–1651. 352 indexed citations
3.
Singh, Rajinder, D. C. Carroll, Jianing Huang, et al.. (2015). Developing structure–activity relationships from an HTS hit for inhibition of the Cks1–Skp2 protein–protein interaction. Bioorganic & Medicinal Chemistry Letters. 25(22). 5199–5202. 25 indexed citations
4.
Golan, Amnon, Elah Pick, Lyuben Tsvetkov, et al.. (2010). Centrosomal Chk2 in DNA damage responses and cell cycle progession. Cell Cycle. 9(13). 2647–2656. 21 indexed citations
5.
Tsvetkov, Lyuben, et al.. (2010). The ubiquitin–proteasome system and assays to determine responses to inhibitors. Expert Opinion on Drug Discovery. 5(12). 1221–1236. 5 indexed citations
6.
Tsvetkov, Lyuben, et al.. (2008). Approaches to Discovering Drugs that Regulate E3 Ubiquitin Ligases. PubMed. 153–170. 2 indexed citations
7.
Tsvetkov, Lyuben & David F. Stern. (2005). Interaction of Chromatin-associated Plk1 and Mcm7. Journal of Biological Chemistry. 280(12). 11943–11947. 44 indexed citations
8.
Tsvetkov, Lyuben, et al.. (2005). The Plk1 Polo Box Domain Mediates a Cell Cycle and DNA Damage Regulated Interaction with Chk2. Cell Cycle. 4(4). 602–610. 18 indexed citations
9.
Tsvetkov, Lyuben. (2004). Polo‐like Kinases and Chk2 at the Interface of DNA Damage Checkpoint Pathways and Mitotic Regulation. IUBMB Life. 56(8). 449–456. 6 indexed citations
10.
Tsvetkov, Lyuben & David F. Stern. (2004). Phosphorylation of Plk1 at S137 and T210 is Inhibited in Response to DNA Damage. Cell Cycle. 4(1). 166–171. 54 indexed citations
11.
Tsvetkov, Lyuben, Xingzhi Xu, Jia Li, & David F. Stern. (2003). Polo-like Kinase 1 and Chk2 Interact and Co-localize to Centrosomes and the Midbody. Journal of Biological Chemistry. 278(10). 8468–8475. 119 indexed citations
12.
Xu, Xingzhi, Lyuben Tsvetkov, & David F. Stern. (2002). Chk2 Activation and Phosphorylation-Dependent Oligomerization. Molecular and Cellular Biology. 22(12). 4419–4432. 148 indexed citations
13.
Mamillapalli, Ramanaiah, Nadia J. Gavrilova, Valia T. Mihaylova, et al.. (2001). PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27KIP1 through the ubiquitin E3 ligase SCFSKP2. Current Biology. 11(4). 263–267. 193 indexed citations
14.
Duan, Hangjun, Lyuben Tsvetkov, Ying Song, et al.. (2001). Promotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: Association with inhibition of p27 accumulation. Molecular Carcinogenesis. 30(1). 37–46. 35 indexed citations
15.
Yeh, Kun‐Huei, et al.. (2001). The F-Box Protein SKP2 Binds to the Phosphorylated Threonine 380 in Cyclin E and Regulates Ubiquitin-Dependent Degradation of Cyclin E. Biochemical and Biophysical Research Communications. 281(4). 884–890. 48 indexed citations
16.
Tsvetkov, Lyuben, et al.. (1999). p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2 complex through phosphorylated Thr187 in p27. Current Biology. 9(12). 661–S2. 683 indexed citations breakdown →
17.
Kunnev, Dimiter, Lyuben Tsvetkov, Boyka Anachkova, & George Russev. (1997). Clusters of Replicons That Fire Simultaneously May Be Organized into Superloops. DNA and Cell Biology. 16(9). 1059–1065. 8 indexed citations
18.
Tsvetkov, Lyuben, et al.. (1997). Effect of mimosine on DNA synthesis in mammalian cells.. PubMed. 57(11). 2252–5. 17 indexed citations
19.
Tsvetkov, Lyuben & George Russev. (1996). Decreased Rates of Replicon Initiation in Mammalian Cells. European Journal of Biochemistry. 237(2). 489–495. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026